Skip to the main content.
Other Therapy Areas

Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.

Learn More →

News and Press Releases

Read Veristat news and press releases to learn about our CRO service growth, geographic expansion in Europe and Asia, biotechnology preferred partnerships and small CRO acquisitions.

Veristat Congratulates Agios on the FDA Approval of TIBSOVO®

The First Targeted Therapy for Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia and...

Veristat is Recognized on the Inc. 5000 List of America’s Fastest-Growing Private Companies for the 4th Consecutive Year

 Veristat’s Continued Innovation of Its Clinical Development Strategies and Services Allow the...

Veristat Recognized for a Third Consecutive Year on the Inc. 5000 List of America’s Fastest-Growing Private Companies

Veristat’s Growth Positively Impacts Our Ability to Help Clients Achieve Regulatory Approval of...

Veristat and AOBiome Establish a Preferred Partnership To Support Ongoing & Impending Clinical Programs

SOUTHBOROUGH, MA –  June 19, 2017 – Veristat, a full service Clinical Research Organization (CRO),...

Veristat Congratulates TESARO on the FDA Approval of ZEJULA™

SOUTHBOROUGH, MA –  May 30, 2017 –   Veristat, a full service Clinical Research Organization (CRO),...

Veristat Acknowledged on Boston Business Journal’s “Fast 50” List for a Second Consecutive Year

Ranked as one of the Top 50 Fastest Growing Private Companies in Massachusetts

Veristat Appoints James Roach, MD as Chief Medical Officer

Veristat Strengthens its Clinical Operations, Medical and Regulatory Affairs Offerings

...

Veristat Formalizes its Strategic Decision Consulting Services

SOUTHBOROUGH, MA –  November 01, 2016 – Veristat, a full-service consultative Clinical Research...

Veristat Strengthens Its Long-Standing Relationship with Aegerion Pharmaceuticals

Veristat, a full service Clinical Research Organization (CRO), announced today the signing of a...

Veristat Acknowledged for its Rapid Growth on the Inc. 5000 List of America’s Fastest-Growing Private Companies

Veristat Continues To Be Recognized for Its Positive Impact & Company Growth

SOUTHBOROUGH, MA –...

Veristat Article “Adaptive Designs- Recent Advancement in Clinical Trials” Published in “Journal of Bioanalysis & Biostatistics”

Two of Veristat’s statistical and adaptive design experts submitted a research paper which was...

Veristat Strengthens Statistical Consulting and Adaptive Design Trial Expertise With Appointment of Mark Chang

Appoints Mark Chang as Senior Vice President of Strategic Statistical Consulting

SOUTHBOROUGH,...